液相色谱质谱联用技术在花生四烯酸代谢产物检测中的应用进展
|
摘要
花生四烯酸(arachidonic acid,AA)代谢产物是多种疾病的生物标志物,精确的定性、定量分析在研究相关疾病的发展机制、诊断和预测中具有重要价值。目前,已经鉴定的AA代谢产物主要包括四大类:前列腺素、血栓素、白三烯和羟基脂肪酸。由于绝大多数AA代谢产物在生物样本中含量极低,因此常规检测技术无法准确对其进行定性和定量分析。近年来,液相色谱质谱联用(LC-MS)分析技术在内源性小分子的检测分析中显示出巨大的优势,分别表现为高分辨飞行时间质谱(Q-TofMS)和三重四极杆线性离子阱质谱(Q-TrapMS)强大的定性和定量能力。本文对近些年LC-MS技术在AA代谢产物检测中的应用展开综述。
Arachidonic acid(AA) metabolites are biomarkers of various diseases. Accurate qualitative and quantitative analysis is of great value in studying the development mechanism,diagnosis and prediction of related diseases. At present,the identified AA metabolites mainly include four major classes:prostaglandins,thromboxanes,leukotrienes,and hydroxy fatty acids. Since most AA metabolites are extremely rare in biological samples,qualitative and quantitative analysis of them cannot be accomplished by conventional detection techniques. In recent years,liquid chromatography-mass spectrometry(LC-MS) analysis has shown great advantages in the detection and analysis of endogenous small molecules,which are characterized by highresolution time-of-flight mass spectrometry(Q-TofMS) and triple quadrupole linear ion for their qualitative and quantitative capabilities,respectively. This article reviews the application of LC-MS technology in the detection of AA metabolites in recent years.
Arachidonic acid(AA) metabolites are biomarkers of various diseases. Accurate qualitative and quantitative analysis is of great value in studying the development mechanism,diagnosis and prediction of related diseases. At present,the identified AA metabolites mainly include four major classes:prostaglandins,thromboxanes,leukotrienes,and hydroxy fatty acids. Since most AA metabolites are extremely rare in biological samples,qualitative and quantitative analysis of them cannot be accomplished by conventional detection techniques. In recent years,liquid chromatography-mass spectrometry(LC-MS) analysis has shown great advantages in the detection and analysis of endogenous small molecules,which are characterized by highresolution time-of-flight mass spectrometry(Q-TofMS) and triple quadrupole linear ion for their qualitative and quantitative capabilities,respectively. This article reviews the application of LC-MS technology in the detection of AA metabolites in recent years.
引文
[1]YAGAMI T,YAMAMOTO Y,KOMA H.Physiological and pathological Roles of 15-deoxy-delta12,14-prostaglandin J2 in the central nervous system and neurological diseases[J].Mol Neurobiol,2018,55(3):2227
[2]YAGAMI T,KOMA H,YAMAMOTO Y.Pathophysiological roles of cyclooxygenases and prostaglandins in the central nervous system[J].Mol Neurobiol,2016,53(7):4754
[3]YAGAMI T,UEDA K,ASAKURA K,et al.Human groupⅡAsecretory phospholipase A2 induces neuronal cell death via apoptosis[J].J Neurochem,2002,61(1):114
[4]PHILLIS JW,O’REGAN MH.The role of phospholipases,cyclooxygenases,and lipoxygenases in cerebral ischemic/traumatic injuries[J].Critic Rev Neurobiol,2003,15(1):61
[5]YAGAMI T,UEDA K,ASAKURA K,et al.GroupⅠB secretory phospholipase A2 induces cell death in the cultured cortical neurons:a possible involvement of its binding sites[J].Brain Res,2002,949(1-2):197
[6]YAGAMI T,UEDA K,ASAKURA K,et al.GroupⅠB secretory phospholipase A2 induces neuronal cell death via apoptosis[J].JNeurochem,2002,81(3):449
[7]YAGAMI T.Cerebral arachidonate cascade in dementia:Alzheimer’s disease and vascular dementia[J].Curr Neuropharmacol,2006,4(1):87
[8]金力超,范玉明,侯晓蓉,等.色谱联用技术在药物分析中的应用特点和新趋势[J].药物分析杂志,2015,35(9):1520JIN LC,FAN YM,HOU XR,et al.Application and tendency of chromatographic hyphenated techniques in pharmaceutical analysis[J].Chin J Pharm Anal,2015,35(9):1520
[9]BECKER S,KORTZ L,HELMSCHRODT C,et al.LC-MS-based metabolomics in the clinical laboratory[J].J Chromatogr B Anal Technol Biomed Life Sci,2012,883-884(1):68
[10]METZ TO,ZHANG Q,PAGE J S,et al.The future of liquid chromatography-mass spectrometry(LC-MS)in metabolic profiling and metabolomic studies for biomarker discovery[J].Biomark Med,2007,1(1):159
[11]ROUX A,LISON D,JUNOT C,et al.Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology:A review[J].Clin Biochem,2011,44(1):119
[12]ZHANG A,SUN H,WANG P,et al.Modern analytical techniques in metabolomics analysis[J].Analyst,2012,137(2):293
[13]ZHOU B,XIAO J F,TULI L,et al.LC-MS-based metabolomics[J].Molecular Biosystems,2012,8(2):470
[14]HARKEWICZ R,FAHY E,ANDREYEV A,et al.Arachidonatederived dihomoprostaglandin production observed in endotoxinstimulated macrophage-like cells[J].J Biol Chem,2007,282(5):2899
[15]YANG R,CHIANG N,OH SF,et al.Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes[J].Curr Protoc Immunol,2011,Chapter 14:Unit 14.26
[16]GACHET MS,RHYN P,BOSCH OG,et al.A quantitiative LC-MS/MS method for the measurement of arachidonic acid,prostanoids,endocannabinoids,N-acylethanolamines and steroids in human plasma[J].J Chromatogr B Analyt Technol Biomed Life Sci,2015,976-977:6
[17]SHINDE DD,KIM KB,OH KS,et al.LC-MS/MS for the simultaneous analysis of arachidonic acid and 32 related metabolites in human plasma:basal plasma concentrations and aspirin-induced changes of eicosanoids[J].J Chromatogr B Analyt Technol Biomed Life Sci,2012,911(5):113
[18]THOMAS A,HOPFGARTNER G,GIROUD C,et al.Quantitative and qualitative profiling of endocannabinoids in human plasma using a triple quadrupole linear ion trap mass spectrometer with liquid chromatography[J].Rapid Commun Mass Spectrom,2009,23(5):629
[19]OZALP A,BARROSO B.Simultaneous quantitative analysis of N-acylethanolamides in clinical samples[J].Anal Biochem,2009,395(1):68
[20]BALVERS MG,VERHOECKX KC,WITKAMP RF.Development and validation of a quantitative method for the determination of 12endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry[J].J Chromatogr B,2009,877(14-15):1583
[21]LAM PM,MARCZYLO TH,ELTALATINI M,et al.Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma[J].Anal Biochem,2008,380(2):195.
[22]TURPEINEN U,H?M?L?INEN E,STENMAN UH.Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci,2008,862(1-2):113
[23]KULLE AE,WELZEL M,HOLTERHUS PM,et al.Implementation of a liquid chromatography tandem mass spectrometry assay for eight adrenal C-21 steroids and pediatric reference data[J].Hormone Res Pediatr,2013,79(1):22
[24]TAYLOR PJ,COOPER DP,GORDON RD,et al.Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry[J].Clin Chem,2009,55(6):1155
[25]BLEWETT AJ,VARMA D,GILLES T,et al.Development and validation of a high-performance liquid chromatography-electrospray mass spectrometry method for the simultaneous determination of 23eicosanoids[J].J Pharm Biomed Anal,2008,46(4):653
[26]SONG J,LIU X,WU J,et al.A highly efficient,high-throughput lipidomics platform for the quantitative detection of eicosanoids in human whole blood[J].Anal Biochem,2013,433(2):181
[27]WANG Y,ARMANDO AM,QUEHENBERGER O,et al.Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples[J].J Chromatogr A,2014,1359:60
[28]HARRIS SG,PADILLA J,KOUMAS L,et al.Prostaglandins as modulators of immunity[J].Trends Immunol,2002,23(3):144
[29]RICCIOTTI E.Prostaglandins and inflammation[J].Arterioscler Thromb Vasc Biol,2011,31:986
[30]VANE J,CORIN RE.Prostacyclin:a vascular mediator[J].Eur J Vascul Endovasc Surg Off J Eur Soc Vascul Surg,2003,26(6):571
[31]WU KK,LIOU J Y.Cellular and molecular biology of prostacyclin synthase[J].Biochem Biophys Res Commun,2005,338(1):45.
[32]GOMBERGMAITLAND M,OLSCHEWSKI H.Prostacyclin therapies for the treatment of pulmonary arterial hypertension[J].Eur Respir J,2008,31(4):891
[33]FARBER HW,LOSCALZO J.Pulmonary arterial Hypertension[J].New England J Med,2004,351(16):1655
[34]SCHANNWELL CM,STEINER S,STRAUER BE.Diagnostics in pulmonary hypertension[J].J Physiol Pharmacol,2007,58(Suppl 5):591
[35]LAIGHT DW,DESAI KM,GOPAUL NK,et al.F2-isoprostane evidence of oxidant stress in the insulin resistant,obese Zucker rat:effects of vitamin E[J].Eur J Pharmacol,1999,377(1):89
[36]GRECO A,MINGHETTI L,LEVI G.Isoprostanes,novel markers of oxidative injury,help understanding the pathogenesis of neurodegenerative diseases[J].Neurochem Res,2000,25(9-10):1357
[37]DEVARAJ S,HIRANY SV,BURK RF,et al.Divergence between LDL oxidative susceptibility and urinary F2-isoprostanes as measures of oxidative stress in type 2 diabetes[J].Clin Chem,2001,47(11):1974
[38]PRATICòD,MY LV,TROJANOWSKI JQ,et al.Increased F2-isoprostanes in Alzheimer’s disease:evidence for enhanced lipid peroxidation in vivo[J].Faseb J,1998,12(15):1777
[39]BASU S,HELMERSSON J.Factors regulating isoprostane formation in vivo[J].Antioxid Redox Sig,2005,7(1-2):221
[40]WANG Z,CIABATTONI G,CR MINON C,et al.Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man[J].J Pharmacol Exp Ther,1995,275(1):94
[41]MORROW JD,HARRIS TM,ND RL.Noncyclooxygenase oxidative formation of a series of novel prostaglandins:analytical ramifications for measurement of eicosanoids[J].Anal Biochem,1990,184(1):1
[42]ROBERTS LJ,MOORE KP,ZACKERT WE,et al.Identification of the major urinary metabolite of the F2-isoprostane 8-isoprostaglandin F2alpha in humans[J].J Biol Chem,1996,271(34):20617
[43]TAYLOR AW,BRUNO RS,TRABER MG.Women and smokers have elevated urinary F2-isoprostane metabolites:a novel extraction and LC-MS methodology[J].Lipids,2008,43(10):925
[44]ENGELS W,KAMPS MA,LEMMENS PJ,et al.Determination of prostaglandins and thromboxane in whole blood by highperformance liquid chromatography with fluorimetric detection[J].J Chromatogr,1988,427(2):209
[45]CHAPPELL DL,XIAO X,RADZISZEWSKI W,et al.Development and validation of a LC/MS/MS method for 6-keto PGF1α,a metabolite of prostacyclin(PGI2)[J].J Pharm Biomedical Anal,2011,56(3):600
[46]HESSE WH,SCHWEER H,SEYBERTH HW,et al.Separation and determination of prostaglandin E1 metabolites by high-performance liquid chromatography[J].J Chromatogr,1990,533:159
[47]OBATA T,NAGAKURA T,KAMMURI M,et al.Determination of9 alpha,11 beta-prostaglandin F2 in human urine and plasma by gas chromatography-mass spectrometry[J].J Chromatogr B Biomed Appl,1994,655(2):173
[48]DANIEL VC,MINTON TA,BROWN NJ,et al.Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry[J].J Chromatogr B Biomed Appl,1994,653(2):117
[49]WEBER C,HOLLER M,BEETENS J,et al.Determination of6-keto-PGF1 alpha,2,3-dinor-6-keto-PGF1 alpha,thromboxane B2,2,3-dinor-thromboxane B2,PGE2,PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry[J].J Chromatogr,1991,562(1-2):599
[50]DEMERS LM,DERCK DD.A radioimmunoassay for 6-ketoprostaglandin F1 alpha[J].Adv Prostagl Thromb Res,1980,6(6):193
[51]MITCHELL MD.A sensitive radioimmunoassay for 6-ketoprostaglandin F1 alpha:preliminary observations on circulating concentrations[J].Prostaglandins Med,1978,1(1):13
[52]BAXENDALE PM,MARTIN RC,HUGHES KT,et al.Development of scintillation proximity assays for prostaglandins and related compounds[J].Adv Prostagl Thromb Leukotriene Res,1991,21A(1):303
[53]TONAI T,YOKOTA K,YANO T,et al.Enzyme immunoassay of6-ketoprostaglandin F1alpha in a solid phase[J].Biochem Biophy Acta(BBA)-Lipids Lipid Metabol,1985,836(3):335
[54]PRADELLES P,GRASSI J,MACLOUF J.Enzyme immunoassays of eicosanoids using acetylcholine esterase as label:an alternative to radioimmunoassay[J].Anal Chem,1985,57(7):1170
[55]GOLD EW,EDGAR PR.The effect of physiological levels of nonesterified fatty acids on the radioimmunoassay of prostaglandins[J].Prostaglandins,1978,16(6):945
[56]HAMBERG M,SVENSSON J,SAMUELSSON B.Thromboxanes:a new group of biologically active compounds derived from prostaglandin endoperoxides[J].Nutri Rev,2010,44(6):208
[57]ENZLER M,SCHIPP S,NICOLAS LB,et al.Determination of6-keto prostaglandin F1alpha and its metabolites in human plasma by LC-MS/MS[J].J Chromatogr B Analyt Technol Biomed Life Sci,2012,901:67
[58]DAHL JH,van BREEMEN RB.Rapid quantitative analysis of8-iso-prostaglandin-F2alpha using liquid chromatography-tandem mass spectrometry and comparison with an enzyme immunoassay method[J].Anal Biochem,2010,404(2):211
[59]PANCHAUD A,AVOIS L,ROULET M,et al.A validated liquid chromatography-mass spectrometry method for the determination of leukotrienes B4 and B5 produced by stimulated human polymorphonuclear leukocytes[J].Anal Biochem,2005,341(1):58
[60]FORD-HUTCHINSON AW,GRESSER M,YOUNG RN.5-lipoxygenase[J].Annual Rev Biochem,1994,63(1):383
[61]PAUWELS RA,JOOS GF,KIPS JC.Leukotrienes as therapeutic target in asthma[J].Allergy,1995,50(8):615
[62]JIAN W,EDOM RW,XUE X,et al.Quantitation of leukotriene B(4)in human sputum as a biomarker using UPLC-MS/MS[J].JChromatogr B Analyt Technol Biomed Life Sci,2013,932(15):59
[63]DUROUDIER NP,TULAH AS,SAYERS I.Leukotriene pathway genetics and pharmacogenetics in allergy[J].Allergy,2009,64(6):823
[64]PERESTRELO R,SILVA CL,CAMARA JS.Determination of urinary levels of leukotriene B4 using ad highly specific and sensitive methodology based on automatic MEPS combined with UHPLC-PDAanalysis[J].Talanta,2015,144:382
[65]林力.基于AA模型和T细胞模型的抗炎中药筛选研究[D].北京:北京中医药大学,2005LIN L.The Modeling and Screening study of the Anti-inflammation Troditional Chinese Medicines with AA System and T Cell[D].Beijing:Beijing University of Chinese Medicine,2005
[66]MONTUSCHI P,MARTELLO S,FELLI M,et al.Ion trap liquid chromatography/tandem mass spectrometry analysis of leukotriene B4in exhaled breath condensate[J].Rapid Commun Mass Spectrom,2004,18(22):2723
[67]WAN M,GODSON C,GUIRY PJ,et al.Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1[J].Faseb J,2011,25(5):1697
[68]SAMPSON AP.The leukotrienes:mediators of chronic inflammation in asthma[J].Clin Exp Allerg J British Soc Allerg Clin Immunol,1996,26(9):995
[69]YU W,POWELL WS.Analysis of leukotrienes,lipoxins,and monooxygenated metabolites of arachidonic acid by reversed-phase high-pressure liquid chromatography[J].Anal Biochem,1995,226(2):241
[70]TAKAMOTO M,YANO T,SHINTANI T,et al.A highly sensitive and selective method for the determination of leukotriene B4 in human plasma by negative ion chemical ionization/gas chromatography/tandem mass spectrometry[J].J Pharm Biomed Anal,1995,13(12):1465
[71]MIZUGAKI M,HISHINUMA T,SUZUKI N.Determination of leukotriene E4 in human urine using liquid chromatography-tandem mass spectrometry[J].J Chromatogr B Biomed Sci Appl,1999,729(1-2):279
[72]CHAPPELL GP,XIAO X,PICA-MENDEZ A,et al.Quantitative measurement of cysteinyl leukotrienes and leukotriene B4 in human sputum using ultra high pressure liquid chromatography-tandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci,2011,879(3-4):277
[73]LIN W,HUANG MQ,XUE X,et al.A highly sensitive and selective method for the determination of leukotriene B4(LTB4)in ex vivo stimulated human plasma by ultra fast liquid chromatographytandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci,2013,925:54
[74]王志军,贾岛,周建芝,等.冠心病合并糖尿病患者血浆11-dhTXB2水平变化及意义[J].山东医药,2016,56(36):43WANG ZJ,JIA D,ZHOU JZ,et al.Changes in levels of 11-dhTXB2 in patients with coronary heart disease combined with diabetes mellitus[J].Shandong Med J,2016,56(36):43
[75]OBILADE OA,AKANMU AS,BROUGHTON PIPKIN F,et al.Prostacyclin,thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy[J].PLoS One,2017,12(9):e0184345
[76]YASUMOTO A,TOKUOKA SM,KITA Y,et al.Multiplex quantitative analysis of eicosanoid mediators in human plasma and serum:possible introduction into clinical testing[J].J Chromatogr B Analyt Technol Biomed Life Sci,2017,1068-1069:98
[77]ZHU QF,HAO YH,LIU MZ,et al.Analysis of cytochrome P450metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry[J].J Chromatogr A,2015,1410:154
[78]NODE K,HUO Y,RUAN X,et al.Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids[J].Science,1999,285(5431):1276
[79]CHANG NW,WU CT,CHEN DR,et al.High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation[J].J Nutr Biochem,2013,24(1):274
[80]ANTONIPILLAI I,NADLER J,VU EJ,et al.A 12-lipoxygenase product,12-hydroxyeicosatetraenoic acid,is increased in diabetics with incipient and early renal disease[J].J Clin Endocrinol Metabol,1996,81(5):1940
[81]FERREIRO-VERA C,MATA-GRANADOS JM,PRIEGO-CAPOTE F,et al.Automated targeting analysis of eicosanoid inflammation biomarkers in human serum and in the exometabolome of stem cells by SPE-LC-MS/MS[J].Anal Bioanal Chem,2011,399(3):1093
[82]ZHANG W,OTSUKA T,SUGO N,et al.Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia[J].Stroke,2008,39(7):2073
[83]LUNDSTR M S L,LEV NEN B,NORDING M,et al.Asthmatics exhibit altered cxylipin profiles compared to healthy individuals after subway air exposure[J].PLoS One,2011,6(8):e23864
[84]黄毅军,秦骏,李泓杰,等.环氧二十碳三烯酸及其在肝硬化门静脉高压症机制中的研究进展[J].中国普外基础与临床杂志,2016(8):1005HUANG YJ,QIN J,LI HJ,et al.Research progress of epoxyeicosatrienoic acid and its role in regulating development of cirrhotic portal hypertension[J].Chin J Bases Clin General Surg,2016(8):1005
[85]邱笑违,王雯,蒋东桥,等.11,12-环氧二十碳三烯酸对人脐静脉内皮细胞缺氧/复氧损伤的影响[J].中国医学科学院学报,2006,28(6):803QIU XW,WANG W,JIANG DQ,et al.Effect of 11,12-epoxyeicosatrienoic acids on hypoxia/reoxygenation injury in the human umbilical vein endothelial cells[J].Acta Acad Med Sin,2006,28(6):803
[86]王康君,程兆云.急性冠状动脉综合征患者血浆环氧二十碳三烯酸水平与血脂关系及对预后的影响[J].中华实用诊断与治疗杂志,2017(8):766WANG KJ,CHENG ZY.Relationship between levels of plasma epoxyeicosatrienoic acids and serum lipids in patients with acute coronary syndromes and its influence on prognosis[J].J Chin Pract Diagn Therap,2017,(08):766
[87]ANNA A,ANDREY S.Targeting 20-HETE producing enzymes in cancer-rationale,pharmacology,and clinical potential[J].Oncot Therap,2013,6(1):243
[88]宋一萌,李明真,马潞林.AA代谢产物与肿瘤发生和发展的研究进展[J].临床泌尿外科杂志,2017(3):236SONG YM,LI MZ,MA LL.Research advances in the association between arachchidonic acid metaolites and tumorigenesis[J].J Clin Urol,2017(3):236
[89]苏林龙,汪文裴,张洁云.结核病与12-羟基二十碳四烯酸的相关性研究[J].中国医学工程,2017(5):52SU LL,WANG WP,ZHANG JY.Relationship between tuberculosis and 12-hydroxyeicosatetraenoic acid[J].Chin Med Eng,2017(5):52
[90]SUZUKI N,HISHINUMA T,SAGA T,et al.Determination of urinary 12(S)-hydroxyeicosatetraenoic acid by liquid chromatography-tandem mass spectrometry with column-switching technique:sex difference in healthy volunteers and patients with diabetes mellitus[J].J Chromatogr B,2003,783(2):383
[91]SUZUKI N.Mass spectrometry-based quantitative analysis and biomarker discovery[J].Yakugaku Zasshi J Pharm Soc Japan,2011,131(9):1305
[92]ZHU QF,HAO YH,LIU MZ,et al.Analysis of cytochrome P450metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry[J].J Chromatogr A,2015,1410:154
[2]YAGAMI T,KOMA H,YAMAMOTO Y.Pathophysiological roles of cyclooxygenases and prostaglandins in the central nervous system[J].Mol Neurobiol,2016,53(7):4754
[3]YAGAMI T,UEDA K,ASAKURA K,et al.Human groupⅡAsecretory phospholipase A2 induces neuronal cell death via apoptosis[J].J Neurochem,2002,61(1):114
[4]PHILLIS JW,O’REGAN MH.The role of phospholipases,cyclooxygenases,and lipoxygenases in cerebral ischemic/traumatic injuries[J].Critic Rev Neurobiol,2003,15(1):61
[5]YAGAMI T,UEDA K,ASAKURA K,et al.GroupⅠB secretory phospholipase A2 induces cell death in the cultured cortical neurons:a possible involvement of its binding sites[J].Brain Res,2002,949(1-2):197
[6]YAGAMI T,UEDA K,ASAKURA K,et al.GroupⅠB secretory phospholipase A2 induces neuronal cell death via apoptosis[J].JNeurochem,2002,81(3):449
[7]YAGAMI T.Cerebral arachidonate cascade in dementia:Alzheimer’s disease and vascular dementia[J].Curr Neuropharmacol,2006,4(1):87
[8]金力超,范玉明,侯晓蓉,等.色谱联用技术在药物分析中的应用特点和新趋势[J].药物分析杂志,2015,35(9):1520JIN LC,FAN YM,HOU XR,et al.Application and tendency of chromatographic hyphenated techniques in pharmaceutical analysis[J].Chin J Pharm Anal,2015,35(9):1520
[9]BECKER S,KORTZ L,HELMSCHRODT C,et al.LC-MS-based metabolomics in the clinical laboratory[J].J Chromatogr B Anal Technol Biomed Life Sci,2012,883-884(1):68
[10]METZ TO,ZHANG Q,PAGE J S,et al.The future of liquid chromatography-mass spectrometry(LC-MS)in metabolic profiling and metabolomic studies for biomarker discovery[J].Biomark Med,2007,1(1):159
[11]ROUX A,LISON D,JUNOT C,et al.Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology:A review[J].Clin Biochem,2011,44(1):119
[12]ZHANG A,SUN H,WANG P,et al.Modern analytical techniques in metabolomics analysis[J].Analyst,2012,137(2):293
[13]ZHOU B,XIAO J F,TULI L,et al.LC-MS-based metabolomics[J].Molecular Biosystems,2012,8(2):470
[14]HARKEWICZ R,FAHY E,ANDREYEV A,et al.Arachidonatederived dihomoprostaglandin production observed in endotoxinstimulated macrophage-like cells[J].J Biol Chem,2007,282(5):2899
[15]YANG R,CHIANG N,OH SF,et al.Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes[J].Curr Protoc Immunol,2011,Chapter 14:Unit 14.26
[16]GACHET MS,RHYN P,BOSCH OG,et al.A quantitiative LC-MS/MS method for the measurement of arachidonic acid,prostanoids,endocannabinoids,N-acylethanolamines and steroids in human plasma[J].J Chromatogr B Analyt Technol Biomed Life Sci,2015,976-977:6
[17]SHINDE DD,KIM KB,OH KS,et al.LC-MS/MS for the simultaneous analysis of arachidonic acid and 32 related metabolites in human plasma:basal plasma concentrations and aspirin-induced changes of eicosanoids[J].J Chromatogr B Analyt Technol Biomed Life Sci,2012,911(5):113
[18]THOMAS A,HOPFGARTNER G,GIROUD C,et al.Quantitative and qualitative profiling of endocannabinoids in human plasma using a triple quadrupole linear ion trap mass spectrometer with liquid chromatography[J].Rapid Commun Mass Spectrom,2009,23(5):629
[19]OZALP A,BARROSO B.Simultaneous quantitative analysis of N-acylethanolamides in clinical samples[J].Anal Biochem,2009,395(1):68
[20]BALVERS MG,VERHOECKX KC,WITKAMP RF.Development and validation of a quantitative method for the determination of 12endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry[J].J Chromatogr B,2009,877(14-15):1583
[21]LAM PM,MARCZYLO TH,ELTALATINI M,et al.Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma[J].Anal Biochem,2008,380(2):195.
[22]TURPEINEN U,H?M?L?INEN E,STENMAN UH.Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci,2008,862(1-2):113
[23]KULLE AE,WELZEL M,HOLTERHUS PM,et al.Implementation of a liquid chromatography tandem mass spectrometry assay for eight adrenal C-21 steroids and pediatric reference data[J].Hormone Res Pediatr,2013,79(1):22
[24]TAYLOR PJ,COOPER DP,GORDON RD,et al.Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry[J].Clin Chem,2009,55(6):1155
[25]BLEWETT AJ,VARMA D,GILLES T,et al.Development and validation of a high-performance liquid chromatography-electrospray mass spectrometry method for the simultaneous determination of 23eicosanoids[J].J Pharm Biomed Anal,2008,46(4):653
[26]SONG J,LIU X,WU J,et al.A highly efficient,high-throughput lipidomics platform for the quantitative detection of eicosanoids in human whole blood[J].Anal Biochem,2013,433(2):181
[27]WANG Y,ARMANDO AM,QUEHENBERGER O,et al.Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples[J].J Chromatogr A,2014,1359:60
[28]HARRIS SG,PADILLA J,KOUMAS L,et al.Prostaglandins as modulators of immunity[J].Trends Immunol,2002,23(3):144
[29]RICCIOTTI E.Prostaglandins and inflammation[J].Arterioscler Thromb Vasc Biol,2011,31:986
[30]VANE J,CORIN RE.Prostacyclin:a vascular mediator[J].Eur J Vascul Endovasc Surg Off J Eur Soc Vascul Surg,2003,26(6):571
[31]WU KK,LIOU J Y.Cellular and molecular biology of prostacyclin synthase[J].Biochem Biophys Res Commun,2005,338(1):45.
[32]GOMBERGMAITLAND M,OLSCHEWSKI H.Prostacyclin therapies for the treatment of pulmonary arterial hypertension[J].Eur Respir J,2008,31(4):891
[33]FARBER HW,LOSCALZO J.Pulmonary arterial Hypertension[J].New England J Med,2004,351(16):1655
[34]SCHANNWELL CM,STEINER S,STRAUER BE.Diagnostics in pulmonary hypertension[J].J Physiol Pharmacol,2007,58(Suppl 5):591
[35]LAIGHT DW,DESAI KM,GOPAUL NK,et al.F2-isoprostane evidence of oxidant stress in the insulin resistant,obese Zucker rat:effects of vitamin E[J].Eur J Pharmacol,1999,377(1):89
[36]GRECO A,MINGHETTI L,LEVI G.Isoprostanes,novel markers of oxidative injury,help understanding the pathogenesis of neurodegenerative diseases[J].Neurochem Res,2000,25(9-10):1357
[37]DEVARAJ S,HIRANY SV,BURK RF,et al.Divergence between LDL oxidative susceptibility and urinary F2-isoprostanes as measures of oxidative stress in type 2 diabetes[J].Clin Chem,2001,47(11):1974
[38]PRATICòD,MY LV,TROJANOWSKI JQ,et al.Increased F2-isoprostanes in Alzheimer’s disease:evidence for enhanced lipid peroxidation in vivo[J].Faseb J,1998,12(15):1777
[39]BASU S,HELMERSSON J.Factors regulating isoprostane formation in vivo[J].Antioxid Redox Sig,2005,7(1-2):221
[40]WANG Z,CIABATTONI G,CR MINON C,et al.Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man[J].J Pharmacol Exp Ther,1995,275(1):94
[41]MORROW JD,HARRIS TM,ND RL.Noncyclooxygenase oxidative formation of a series of novel prostaglandins:analytical ramifications for measurement of eicosanoids[J].Anal Biochem,1990,184(1):1
[42]ROBERTS LJ,MOORE KP,ZACKERT WE,et al.Identification of the major urinary metabolite of the F2-isoprostane 8-isoprostaglandin F2alpha in humans[J].J Biol Chem,1996,271(34):20617
[43]TAYLOR AW,BRUNO RS,TRABER MG.Women and smokers have elevated urinary F2-isoprostane metabolites:a novel extraction and LC-MS methodology[J].Lipids,2008,43(10):925
[44]ENGELS W,KAMPS MA,LEMMENS PJ,et al.Determination of prostaglandins and thromboxane in whole blood by highperformance liquid chromatography with fluorimetric detection[J].J Chromatogr,1988,427(2):209
[45]CHAPPELL DL,XIAO X,RADZISZEWSKI W,et al.Development and validation of a LC/MS/MS method for 6-keto PGF1α,a metabolite of prostacyclin(PGI2)[J].J Pharm Biomedical Anal,2011,56(3):600
[46]HESSE WH,SCHWEER H,SEYBERTH HW,et al.Separation and determination of prostaglandin E1 metabolites by high-performance liquid chromatography[J].J Chromatogr,1990,533:159
[47]OBATA T,NAGAKURA T,KAMMURI M,et al.Determination of9 alpha,11 beta-prostaglandin F2 in human urine and plasma by gas chromatography-mass spectrometry[J].J Chromatogr B Biomed Appl,1994,655(2):173
[48]DANIEL VC,MINTON TA,BROWN NJ,et al.Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry[J].J Chromatogr B Biomed Appl,1994,653(2):117
[49]WEBER C,HOLLER M,BEETENS J,et al.Determination of6-keto-PGF1 alpha,2,3-dinor-6-keto-PGF1 alpha,thromboxane B2,2,3-dinor-thromboxane B2,PGE2,PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry[J].J Chromatogr,1991,562(1-2):599
[50]DEMERS LM,DERCK DD.A radioimmunoassay for 6-ketoprostaglandin F1 alpha[J].Adv Prostagl Thromb Res,1980,6(6):193
[51]MITCHELL MD.A sensitive radioimmunoassay for 6-ketoprostaglandin F1 alpha:preliminary observations on circulating concentrations[J].Prostaglandins Med,1978,1(1):13
[52]BAXENDALE PM,MARTIN RC,HUGHES KT,et al.Development of scintillation proximity assays for prostaglandins and related compounds[J].Adv Prostagl Thromb Leukotriene Res,1991,21A(1):303
[53]TONAI T,YOKOTA K,YANO T,et al.Enzyme immunoassay of6-ketoprostaglandin F1alpha in a solid phase[J].Biochem Biophy Acta(BBA)-Lipids Lipid Metabol,1985,836(3):335
[54]PRADELLES P,GRASSI J,MACLOUF J.Enzyme immunoassays of eicosanoids using acetylcholine esterase as label:an alternative to radioimmunoassay[J].Anal Chem,1985,57(7):1170
[55]GOLD EW,EDGAR PR.The effect of physiological levels of nonesterified fatty acids on the radioimmunoassay of prostaglandins[J].Prostaglandins,1978,16(6):945
[56]HAMBERG M,SVENSSON J,SAMUELSSON B.Thromboxanes:a new group of biologically active compounds derived from prostaglandin endoperoxides[J].Nutri Rev,2010,44(6):208
[57]ENZLER M,SCHIPP S,NICOLAS LB,et al.Determination of6-keto prostaglandin F1alpha and its metabolites in human plasma by LC-MS/MS[J].J Chromatogr B Analyt Technol Biomed Life Sci,2012,901:67
[58]DAHL JH,van BREEMEN RB.Rapid quantitative analysis of8-iso-prostaglandin-F2alpha using liquid chromatography-tandem mass spectrometry and comparison with an enzyme immunoassay method[J].Anal Biochem,2010,404(2):211
[59]PANCHAUD A,AVOIS L,ROULET M,et al.A validated liquid chromatography-mass spectrometry method for the determination of leukotrienes B4 and B5 produced by stimulated human polymorphonuclear leukocytes[J].Anal Biochem,2005,341(1):58
[60]FORD-HUTCHINSON AW,GRESSER M,YOUNG RN.5-lipoxygenase[J].Annual Rev Biochem,1994,63(1):383
[61]PAUWELS RA,JOOS GF,KIPS JC.Leukotrienes as therapeutic target in asthma[J].Allergy,1995,50(8):615
[62]JIAN W,EDOM RW,XUE X,et al.Quantitation of leukotriene B(4)in human sputum as a biomarker using UPLC-MS/MS[J].JChromatogr B Analyt Technol Biomed Life Sci,2013,932(15):59
[63]DUROUDIER NP,TULAH AS,SAYERS I.Leukotriene pathway genetics and pharmacogenetics in allergy[J].Allergy,2009,64(6):823
[64]PERESTRELO R,SILVA CL,CAMARA JS.Determination of urinary levels of leukotriene B4 using ad highly specific and sensitive methodology based on automatic MEPS combined with UHPLC-PDAanalysis[J].Talanta,2015,144:382
[65]林力.基于AA模型和T细胞模型的抗炎中药筛选研究[D].北京:北京中医药大学,2005LIN L.The Modeling and Screening study of the Anti-inflammation Troditional Chinese Medicines with AA System and T Cell[D].Beijing:Beijing University of Chinese Medicine,2005
[66]MONTUSCHI P,MARTELLO S,FELLI M,et al.Ion trap liquid chromatography/tandem mass spectrometry analysis of leukotriene B4in exhaled breath condensate[J].Rapid Commun Mass Spectrom,2004,18(22):2723
[67]WAN M,GODSON C,GUIRY PJ,et al.Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1[J].Faseb J,2011,25(5):1697
[68]SAMPSON AP.The leukotrienes:mediators of chronic inflammation in asthma[J].Clin Exp Allerg J British Soc Allerg Clin Immunol,1996,26(9):995
[69]YU W,POWELL WS.Analysis of leukotrienes,lipoxins,and monooxygenated metabolites of arachidonic acid by reversed-phase high-pressure liquid chromatography[J].Anal Biochem,1995,226(2):241
[70]TAKAMOTO M,YANO T,SHINTANI T,et al.A highly sensitive and selective method for the determination of leukotriene B4 in human plasma by negative ion chemical ionization/gas chromatography/tandem mass spectrometry[J].J Pharm Biomed Anal,1995,13(12):1465
[71]MIZUGAKI M,HISHINUMA T,SUZUKI N.Determination of leukotriene E4 in human urine using liquid chromatography-tandem mass spectrometry[J].J Chromatogr B Biomed Sci Appl,1999,729(1-2):279
[72]CHAPPELL GP,XIAO X,PICA-MENDEZ A,et al.Quantitative measurement of cysteinyl leukotrienes and leukotriene B4 in human sputum using ultra high pressure liquid chromatography-tandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci,2011,879(3-4):277
[73]LIN W,HUANG MQ,XUE X,et al.A highly sensitive and selective method for the determination of leukotriene B4(LTB4)in ex vivo stimulated human plasma by ultra fast liquid chromatographytandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci,2013,925:54
[74]王志军,贾岛,周建芝,等.冠心病合并糖尿病患者血浆11-dhTXB2水平变化及意义[J].山东医药,2016,56(36):43WANG ZJ,JIA D,ZHOU JZ,et al.Changes in levels of 11-dhTXB2 in patients with coronary heart disease combined with diabetes mellitus[J].Shandong Med J,2016,56(36):43
[75]OBILADE OA,AKANMU AS,BROUGHTON PIPKIN F,et al.Prostacyclin,thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy[J].PLoS One,2017,12(9):e0184345
[76]YASUMOTO A,TOKUOKA SM,KITA Y,et al.Multiplex quantitative analysis of eicosanoid mediators in human plasma and serum:possible introduction into clinical testing[J].J Chromatogr B Analyt Technol Biomed Life Sci,2017,1068-1069:98
[77]ZHU QF,HAO YH,LIU MZ,et al.Analysis of cytochrome P450metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry[J].J Chromatogr A,2015,1410:154
[78]NODE K,HUO Y,RUAN X,et al.Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids[J].Science,1999,285(5431):1276
[79]CHANG NW,WU CT,CHEN DR,et al.High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation[J].J Nutr Biochem,2013,24(1):274
[80]ANTONIPILLAI I,NADLER J,VU EJ,et al.A 12-lipoxygenase product,12-hydroxyeicosatetraenoic acid,is increased in diabetics with incipient and early renal disease[J].J Clin Endocrinol Metabol,1996,81(5):1940
[81]FERREIRO-VERA C,MATA-GRANADOS JM,PRIEGO-CAPOTE F,et al.Automated targeting analysis of eicosanoid inflammation biomarkers in human serum and in the exometabolome of stem cells by SPE-LC-MS/MS[J].Anal Bioanal Chem,2011,399(3):1093
[82]ZHANG W,OTSUKA T,SUGO N,et al.Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia[J].Stroke,2008,39(7):2073
[83]LUNDSTR M S L,LEV NEN B,NORDING M,et al.Asthmatics exhibit altered cxylipin profiles compared to healthy individuals after subway air exposure[J].PLoS One,2011,6(8):e23864
[84]黄毅军,秦骏,李泓杰,等.环氧二十碳三烯酸及其在肝硬化门静脉高压症机制中的研究进展[J].中国普外基础与临床杂志,2016(8):1005HUANG YJ,QIN J,LI HJ,et al.Research progress of epoxyeicosatrienoic acid and its role in regulating development of cirrhotic portal hypertension[J].Chin J Bases Clin General Surg,2016(8):1005
[85]邱笑违,王雯,蒋东桥,等.11,12-环氧二十碳三烯酸对人脐静脉内皮细胞缺氧/复氧损伤的影响[J].中国医学科学院学报,2006,28(6):803QIU XW,WANG W,JIANG DQ,et al.Effect of 11,12-epoxyeicosatrienoic acids on hypoxia/reoxygenation injury in the human umbilical vein endothelial cells[J].Acta Acad Med Sin,2006,28(6):803
[86]王康君,程兆云.急性冠状动脉综合征患者血浆环氧二十碳三烯酸水平与血脂关系及对预后的影响[J].中华实用诊断与治疗杂志,2017(8):766WANG KJ,CHENG ZY.Relationship between levels of plasma epoxyeicosatrienoic acids and serum lipids in patients with acute coronary syndromes and its influence on prognosis[J].J Chin Pract Diagn Therap,2017,(08):766
[87]ANNA A,ANDREY S.Targeting 20-HETE producing enzymes in cancer-rationale,pharmacology,and clinical potential[J].Oncot Therap,2013,6(1):243
[88]宋一萌,李明真,马潞林.AA代谢产物与肿瘤发生和发展的研究进展[J].临床泌尿外科杂志,2017(3):236SONG YM,LI MZ,MA LL.Research advances in the association between arachchidonic acid metaolites and tumorigenesis[J].J Clin Urol,2017(3):236
[89]苏林龙,汪文裴,张洁云.结核病与12-羟基二十碳四烯酸的相关性研究[J].中国医学工程,2017(5):52SU LL,WANG WP,ZHANG JY.Relationship between tuberculosis and 12-hydroxyeicosatetraenoic acid[J].Chin Med Eng,2017(5):52
[90]SUZUKI N,HISHINUMA T,SAGA T,et al.Determination of urinary 12(S)-hydroxyeicosatetraenoic acid by liquid chromatography-tandem mass spectrometry with column-switching technique:sex difference in healthy volunteers and patients with diabetes mellitus[J].J Chromatogr B,2003,783(2):383
[91]SUZUKI N.Mass spectrometry-based quantitative analysis and biomarker discovery[J].Yakugaku Zasshi J Pharm Soc Japan,2011,131(9):1305
[92]ZHU QF,HAO YH,LIU MZ,et al.Analysis of cytochrome P450metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry[J].J Chromatogr A,2015,1410:154
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |